Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingavirin for Influenza and Acute Viral Infections
NCT03154515Phase 4Completed
- Sponsor
- Valenta Pharm
- Start
- Jan 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in influenza and acute respiratory viral infection (ARVI) comparing Ingavirin with Placebo (2 arms). Primary endpoint: Time to resolution of fever at 7 days. Started Jan 2010; status: completed.
02
Drugs
Ingavirin
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03154515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154515.